Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

353P - Heterogeneity of tertiary lymphoid structures predicts distinct malignancy and immune microenvironment in prostate cancer

Date

07 Dec 2024

Session

Poster Display session

Presenters

Wenhao Xu

Citation

Annals of Oncology (2024) 35 (suppl_4): S1531-S1543. 10.1016/annonc/annonc1690

Authors

W. Liu1, H. Zhang2, D. Ye3, W. Xu2

Author affiliations

  • 1 Thoracic Surgery Dept., Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200127 - Shanghai/CN
  • 2 Urology, Fudan University Shanghai Cancer Center, 200032 - Shanghai/CN
  • 3 Department Of Urology, Fudan University Shanghai Cancer Center, 200032 - Shanghai/CN

Resources

This content is available to ESMO members and event participants.

Abstract 353P

Background

Tertiary lymphoid structures (TLS) are organized aggregations of immune cells under pathological conditions. However, the presence and predictive value of TLS heterogeneity in maturation and spatial location in prostate cancer (PCa) remains unknown.

Methods

Immunohistochemistry and multispectral fluorescence techniques were used to assess the heterogeneity of TLS and the characteristics of TME cell infiltration. The prognostic impact of TLS heterogeneity was thoroughly investigated in 701 prostate cancer patients from TCGA and Fudan University Shanghai Cancer Center cohorts. The relationship between TLS heterogeneity and immunoreactivity or malignancy of PCa was assessed by quantifying immune cell infiltration.

Results

In PCa, TLS is predominantly found within the tumor, and patients with positive intratumoral TLS (intra-TLS) have a longer disease-free survival interval and progression-free interval. The maturity of peritumoral TLS (peri-TLS) was lower than that of intra-TLS, and Treg infiltration was significantly increased, suggesting an immunosuppressive role of the tumor microenvironment. Interestingly, multispectral fluorescence immunohistochemistry and immunofluorescence were also suggestive of high PDL1 expression, more Tregs and less high endothelial venules in the vicinity of immature TLS.

Conclusions

This study reveals the predictive value of differences in spatial heterogeneity and maturity of TLS in relation to the clinical features as well as prognosis of PCa. It provides new ideas for the selection of future PCa immunotherapy population.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Fudan University Shanghai Cancer Center.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.